KW-6500 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	4

6. パーキンソン病

---

臨床試験数 : 2,298 /  薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01063621 (ClinicalTrials.gov)	January 2010	4/2/2010	Extended Long-Term Safety Study of KW-6500	Phase 3 Study of KW-6500 (Safety Study for Extended Long-Term Self-Injection at Home in Patients With Parkinson's Disease)	Parkinson's Disease	Drug: KW-6500	Kyowa Hakko Kirin Co., Ltd	NULL	Completed	20 Years	N/A	All	27	Phase 3	Japan
2	NCT01058291 (ClinicalTrials.gov)	January 2010	27/1/2010	Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500	Phase 3 Study of KW-6500 (Placebo-Controlled Double-Blind Crossover Comparative Study in Patients With Parkinson's Disease)	Parkinson's Disease	Drug: KW-6500;Drug: KW-6500 Placebo	Kyowa Hakko Kirin Co., Ltd	NULL	Completed	20 Years	N/A	All	31	Phase 3	Japan
3	NCT00955318 (ClinicalTrials.gov)	July 2009	7/8/2009	Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease	Phase 3 Study of KW-6500 (Safety Study for Long-Term Self-Administration at Home in Patients With Parkinson's Disease	Parkinson's Disease	Drug: KW-6500	Kyowa Hakko Kirin Co., Ltd	NULL	Completed	20 Years	N/A	All	58	Phase 3	Japan
4	NCT00610103 (ClinicalTrials.gov)	November 2007	22/1/2008	Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy	A Phase 2 Clinical Study of KW-6500 (Apomorphine Hydrochloride) in Patients With Parkinson's Disease	Parkinson's Disease	Drug: apomorphine hydrochloride	Kyowa Kirin Co., Ltd.	NULL	Completed	20 Years	N/A	All	16	Phase 2	Japan